Jupiter Life Line Hospitals Reports Mixed Financial Results for March 2025
Jupiter Life Line Hospitals announced its financial results for the quarter ending March 2025, showcasing its highest quarterly operating profit of Rs 78.26 crore and a 23.95% operating profit margin. While net sales reached Rs 326.74 crore, profit after tax declined to Rs 44.86 crore, indicating mixed performance trends.
Jupiter Life Line Hospitals has recently reported its financial results for the quarter ending March 2025, revealing a mix of positive and challenging trends within its performance metrics. The company has achieved its highest quarterly operating profit of Rs 78.26 crore, marking a consistent growth trajectory over the last five quarters. Additionally, the operating profit margin reached a notable 23.95%, indicating an enhancement in operational efficiency.On the sales front, Jupiter Life Line Hospitals recorded net sales of Rs 326.74 crore, the highest in the past five quarters, suggesting a favorable trend in revenue generation. However, the company faced some headwinds, as its profit after tax (PAT) for the quarter stood at Rs 44.86 crore, reflecting a decline of 6.5% compared to the average PAT of the previous four quarters, which was Rs 47.98 crore. This indicates a negative trend in profitability despite the positive developments in other areas.
In light of these results, there has been an adjustment in evaluation for Jupiter Life Line Hospitals, with the score reflecting recent performance changes.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
